- Titre
- Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial
- Créateurs - sans rôle
- Chipepo Kankasa - University of ZambiaAnaïs Mennecier - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEIBeninwendé SakanaJean-Pierre Molès - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEIMwiya Mwiya - University Teaching HospitalCatherine Chunda-Liyoka - University Teaching HospitalMorgana d'Ottavi - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEISouleymane Tassembedo - Centre MurazMaria Wilfred-Tonga - University Teaching HospitalPaulin Fao - Centre MurazDavid Rutagwera - University Teaching HospitalBeauty Matoka - University Teaching HospitalDramane Kania - Centre MurazOusmane Taofiki - Centre MurazThorkild Tylleskär - University of BergenPhilippe van de Perre - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEINicolas Nagot - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
- Détails de publication
- The Lancet, Vol.403(10434), pp.1362-1371
- Identifiants
- 99150716809311
- Unité académique
- Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
- Langue
- English
- Type de ressource
- Journal article
- Champs locaux
- hal-04702032
Article de revue
Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial
The Lancet, Vol.403(10434), pp.1362-1371
04/2024
Indicateurs
1 Consultations de la notice